C07D 235/12
Radicals substituted by oxygen atoms
C07D235/12 (Radicals substituted by oxygen atoms) appears on 282 US grants and 247 published applications in this corpus.
Search patents in C07D- Granted patents
- 282
- Published applications
- 247
- Assignees
- 189
- Inventors
- 1,121
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 2 | 0 |
| 1980 | 2 | 0 |
| 1981 | 3 | 0 |
| 1982 | 4 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 3 | 0 |
| 1986 | 4 | 0 |
| 1987 | 4 | 0 |
| 1988 | 2 | 0 |
| 1989 | 2 | 0 |
| 1990 | 8 | 0 |
| 1991 | 6 | 0 |
| 1992 | 7 | 0 |
| 1993 | 5 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 4 | 0 |
| 1997 | 4 | 0 |
| 1998 | 5 | 0 |
| 1999 | 6 | 0 |
| 2000 | 9 | 0 |
| 2001 | 11 | 0 |
| 2002 | 10 | 7 |
| 2003 | 3 | 10 |
| 2004 | 2 | 13 |
| 2005 | 5 | 11 |
| 2006 | 10 | 18 |
| 2007 | 4 | 10 |
| 2008 | 8 | 13 |
| 2009 | 11 | 11 |
| 2010 | 11 | 15 |
| 2011 | 7 | 10 |
| 2012 | 9 | 11 |
| 2013 | 12 | 13 |
| 2014 | 10 | 12 |
| 2015 | 11 | 12 |
| 2016 | 7 | 13 |
| 2017 | 13 | 7 |
| 2018 | 5 | 6 |
| 2019 | 7 | 9 |
| 2020 | 2 | 7 |
| 2021 | 6 | 10 |
| 2022 | 5 | 5 |
| 2023 | 7 | 9 |
| 2024 | 5 | 8 |
| 2025 | 8 | 4 |
| 2026 | 4 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- One-pot homogeneous process for the large scale manufacture of 2-substituted benzimidazoles4 Aug 2026US 12,698,267 B2Ecolab USA Inc.
- Compositions, formulations, and methods for skin treatment3 Mar 2026US 12,564,547 B2Oddity Labs, LLC
- Compounds for treating respiratory disease17 Feb 2026US 12,552,770 B2TMEM16A Limited
- Substituted benzimidazole derivative and use thereof13 Jan 2026US 12,522,569 B2Chengdu FANXI Biopharma Co., Ltd.
- Treatment of Acanthamoeba or Balamuthia trophozoites and/or cysts7 Oct 2025US 12,433,872 B2Georgia State University Research Foundation, Inc.
- Fluorinated mu-opioid receptor agonists10 Sep 2026US 2026/0265205 A1The United State of America, as represented by the Secretary, Department of Health and Human
- Ligand-enabled scalable c-h hydroxylation of benzoic and phenylacetic acids at room temperature2 Apr 2026US 2026/0092029 A1The Scripps Research Institute
- Calix[4]arenes with high anticancer activity15 Jan 2026US 2026/0015339 A1Centre Hospitalier RéGional De Grenoble
- Method for preparing 4-[5-[bis(2-chloroethyl)amino]-1-methyl-1h-benzo[d]imidazol-2-yl]butyric acid alkyl esters and formylated derivatives25 Sep 2025US 2025/0295636 A1Heraeus Precious Metals GmbH & Co. KG
- Acetyl-coa synthetase 2 (acss2) inhibitors and methods using same31 Jul 2025US 2025/0243168 A1The Wistar Institute
Most cited
By later US patents
- Azole derivatives and fused bicyclic azole derivatives as therapeutic agents77US 7,361,678 B2TransTech Pharma, Inc. · 2008
- Disubstituted bicyclic heterocycles, the preparation thereof, and their use as pharmaceutical compositions73US 6,414,008 B1Boehringer Ingelheim Pharma GMBH & CO.KG · 2002
- Condensed 5-membered heterocyclic compounds, processes for preparing them and pharmaceutical preparations containing these compounds72US 5,434,150 ADr. Karl Thomae GmbH · 1995
- Quinoline compounds71US 4,876,346 AAmerican Home Products Corporation · 1989
- Benzoheterocycles and their uses as MEK inhibitors71US 6,469,004 B1Warner-Lambert Company · 2002